MedPage Today on MSN

New TYK2 inhibitors for psoriasis achieve high clearance rates in randomized trials

Three-fourths of patients have 70-75% improvement at 16 weeks with zasocitinib, envudeucit ...
GlobalData on MSN

Actinogen treats first patient in XanaMIA trial for Alzheimer’s

Actinogen anticipates final topline efficacy and safety results for the full 36-week treatment period in November 2026.

AROA Biosurgery Completes Randomised Controlled Trial for Symphony™; Preliminary Read-Out indicates Primary Endpoint Met

Aroa Biosurgery Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial achieved its primary endpoint.

AstraZeneca reports positive data from Phase III trial of efzimfotase alfa

AstraZeneca has reported positive results from the efzimfotase alfa Phase III clinical trial programme for hypophosphatasia ...
AHA/ASA Journals

Designing Medically Tailored Meal Interventions: The Food as Medicine for Families (FAME-F) Factorial Randomized Clinical Trial

BACKGROUND: Medically tailored meals (MTM) have unanswered implementation questions. Providing MTM for a specific individual, ...
Medscape

New TAVR Embolic Protection Device Holds Its Own in Head-to-Head Trial: PROTECT H2H

A device designed to capture more TAVR procedural debris proves noninferior to an existing device in a large trial, but the ...

ImmunityBio Confirms Statistical Power in Pivotal Randomized BCG-Naïve NMIBC Trial to Detect Clinically Meaningful Differences Between ANKTIVA® Plus BCG Versu…

ImmunityBio, Inc. (NASDAQ: IBRX), a vertically integrated, commercial-stage immunotherapy company, today announced that based ...
TCTMD

Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

The controversial findings had interventional cardiologists looking for answers, with operator experience coming into focus.
Thorax

Inhaled corticosteroid withdrawal and mortality rate in trials of triple therapy inhalers for COPD

The Efficacy and Safety of Triple Therapy in Obstructive Lung Disease (ETHOS) and Informing the Pathway of Chronic ...

NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer

Data presented by Johnson & Johnson at the 2026 European Lung Cancer ConferencePARIS and CAMBRIDGE, Mass., March 30, 2026 (GLOBE NEWSWIRE) ...

Amylyx Pharmaceuticals (AMLX) Winds Up Avexitide Phase 3 Lucidity Trial Enrollment

Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the 7 best small-cap drug manufacturing stocks to buy according to hedge ...